ArticlePain reports2026

Monoclonal antibody inhibition of PAR2 reduces phenotype severity and pain in murine inflammatory bowel disease.

Anne Ritoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.